Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 334 days ago

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

RTTNews | 428 days ago

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 606 days ago

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 980 days ago

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Wednesday, adding to the gains in the previous four sessions, with the benchmark S&P/ASX 200 moving up to near the 8,100 level, following the broadly positive cues from Wall Street overnight, with gains financial and technology stocks partially offset by weakness in energy stocks.

RTTNews | 9 minutes ago

Asian Markets Trade Mixed

Asian stock markets are trading mixed on Wednesday, following the broadly positive cues from Wall Street overnight, amid the ongoing uncertainty about the tariff war and fears of a global economic slowdown. There are also some positive developments on the trade front, with US Commerce Secretary Howard Lutnick telling CNBC the Trump administration has reached its first trade deal.

RTTNews | 36 minutes ago

Sensex, Nifty Likely To Open On Cautious Note

Indian shares may open on a cautious note Wednesday after a slew of U.S. companies suspended or tweaked their full year guidance and Samsung Electronics flagged macroeconomic uncertainties due to trade tensions and a slowdown in global growth.

RTTNews | 1h 1min ago

Thai Stock Market May Extend Winning Streak

The Thai stock market has moved higher in three straight sessions, gathering almost 25 points or 2 percent along the way. The Stock Exchange of Thailand now sits just above the 1,170-point plateau and it may tick higher again on Wednesday.

RTTNews | 1h 36min ago

EURUSD	1.13734	GBPUSD	1.339	AUDUSD	0.63993
USDJPY	142.469	USDCAD	1.38412	USDCHF	0.82357

Advertisement

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS